MassIVE MSV000083763

Partial Public

SETD1A protects from senescence through regulation of the mitotic gene expression program

Subscribe Comment Reanalyze Spectra Add Reanalysis

Description

SETD1A, a Set1/COMPASS family member maintaining histone-H3-lysine-4 (H3K4) methylation on transcriptionally active promoters, is overexpressed in breast cancer. Here we show that SETD1Asupports mitotic processes and consequentially, its knockdown induces senescence, independent of mutations in p53, RBand p16, known senescence mediators. The following labeling scheme was used: bridge_1; TMT1_126 A549_GFPctrl_Day3_Repl1; TMT1_127n A549_shSETD1A#1_Day3_Repl1; TMT1_127c A549_shSETD1A#2_Day3_Repl1; TMT1_128n A549_GFPctrl_Day5_Repl1; TMT1_128c A549_shSETD1A#1_Day5_Repl1; TMT1_129n A549_shSETD1A#2_Day5_Repl1; TMT1_129c M231_GFPctrl_Day3; TMT1_130n M231_GFP_ctrl_Day5; TMT1_130c bridge_2; TMT1_131 bridge_1; TMT2_126 A549_GFP_ctrl_Day3_Repl2; TMT2_127n A549_shSETD1A#1_Day3_Repl2; TMT2_127c A549_shSETD1A#2_Day3_Repl2; TMT2_128n A549_GFPctrl_Day5_Repl2; TMT2_128c A549_shSETD1A#1_Day5_Repl2; TMT2_129n A549_shSETD1A#2_Day5_Repl2; TMT2_129c M231_shSETD1A#2_Day3; TMT2_130n M231_shSETD1A#2_Day5; TMT2_130c bridge_2; TMT2_131 [doi:10.25345/C58D2W] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: SETD1A, human cell lines, full proteome, TMT10, SPS-MS3, Orbitrap Fusion

Contact

Principal Investigators:
(in alphabetical order) 		Shyamala Maheswaran, Massachusetts General Hospital Cancer Center and Harvard Medical School Boston, USA
Submitting User: whaas
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

Species

Instrument

Modifications

- Dataset Reanalyses

+ Dataset History

Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.